Interactive effects of ApoE polymorphism, alcohol and smoking on age-related trends of blood pressure levels in elderly men: the Bambuì Cohort Study of Ageing (1997-2008)

Journal of Human Hypertension

Volumn 27, Issue 8, 2013, Pages 497-503

  Leite, M L C ^a   Moriguchi, E H ^b   Lima Costa, M F ^c  

^a INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Alcohol consumption; Apolipoprotein E; Blood pressure; Elderly; Smoking

Indexed keywords

APOLIPOPROTEIN E; LIPID;

AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAZIL; COHORT ANALYSIS; DEATH; DRINKING BEHAVIOR; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MERCURY SPHYGMOMANOMETER; PROSPECTIVE STUDY; PROTEIN POLYMORPHISM; PUBLIC HEALTH; RISK FACTOR; SENESCENCE; SMOKING; SMOKING HABIT; STETHOSCOPE;

AGE FACTORS; AGED; ALCOHOL DRINKING; APOLIPOPROTEINS E; BLOOD PRESSURE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; SMOKING;

EID: 84880283212     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2012.70     Document Type: Article

References (37)

1. Pausova Z, Tramblay J, Hamet P. Gene-environment interactions in hypertension. Cur Hypertens Rep 1999; 1: 42-50
2. Kodavali L, Townsend RR. Alcohol and its relationship to blood pressure. Cur Hypertens Rep 2006; 8: 338-344
3. Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure. Evidence from the health survey for England. Hypertension 2001; 37: 187-193
4. Mahley RW, Rall SC. Apolipoprotein E: Far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000; 1: 507-537
5. Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007; 298: 1300-1311
6. Marques-Vidal P, Bongard V, Ruidavets J-B, Fauvel J, Hanaire-Broutin H, Perret B et al. Obesity and alcohol modulate the effect of apolipoprotein E polymorphism on lipids and insulin. Obes Res 2003; 11: 1200-1206
7. Talmud PJ, Stephens JW, Hawe E, Demissie S, Cupples LA, Hurel SJ et al. The significant increase in cardiovascular disease risk in ApoE e4 carriers is evident only in men who smoke: Potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet 2005; 69: 613-622
8. Hamet P. Apolipoprotein E alleles and hypertension: Controversy or lack of understanding? J Hypertens 2002; 20: 1941-1942
9. Kauma H, Savolainen MJ, Rantala AO, Lilja M, Kervinen K, Reunanen A et al. Apolipoprotein E phenotype determines the effect of alcohol on blood pressure in middle-aged men. Am J Hypertens 1998; 11: 1334-1343
10. Correa Leite ML, Lima-Costa MF, Moriguchi EH. Age-related trends of blood pressure levels by apolipoprotein E genotype: The Bambuìcohort study of ageing (1997-2008). Hypertens Res 2013; 36: 270-276
11. Lima-Costa MF, Firmo JOA, Uchoa E. The BambuìCohort Study of Ageing: Methodology and health profile of participants at baseline. Cad Saude Publica 2011; 27(Suppl 3): S327-S335
12. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990; 31: 545-548
13. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2010. Oslo 2009, 282 p. Available from http:// www.whocc.no/filearchive/publications/2010guidelines.pdf
14. Hedeker D, Gibbons RD. Application of random-effects pattern-mixture models for missing data in longitudinal studies. Psychol Methods 1997; 2: 64-78
15. StataCorp. 2009. Stata: Release 11. Statistical Software. College Station, TX: StataCorp L.P.
16. Manolio TA, Bailey-Wilson JE, Collins FS. Genes, environment and the value of prospective cohort studies. Nature Rev Genet 2006; 7: 812-820
17. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M et al. Underestimation of risk associations due to regression dilution in long-term follow- up of prospective studies. Am J Epidemiol 1999; 150: 341-353
18. Klatsky AL, Gunderson E. Alcohol and hypertension: A review. J Am Soc Hypertens 2008; 2: 307-317
19. Sesso HD, Cook NR, Buring JE, Manson JE, Gaziano JM. Alcohol consumption and the risk of hypertension in women and men. Hypertension 2008; 51: 1080-1087
20. McEniery CM, Spratt M, Munnery M, Yarnell J, Lowe GD, Rumley A et al. An analysis of prospective risk factors for aortic stiffness in men: 20-year follow-up from the Caerphilly prospective study. Hypertension 2010; 56: 36-43
21. Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987; 80: 1571-1577
22. Hartung GH, Lawrence SJ, Reeves RS, Foreyt JP. Effect of alcohol and exercise on postprandial lipemia and triglyceride clearance in men. Atherosclerosis 1993; 100: 33-40
23. Ginsberg H, Olefsky J, Farquhar JW, Reaven GM. Moderate ethanol ingestion and plasma triglyceride levels: A study in normal and hypertriglyceridemic persons. Ann Intern Med 1974; 80: 143-149
24. Van de Wiel A. The effect of alcohol on postprandial and fasting triglycerides. Int J Vasc Med 2012; 2012: 862504
25. Nestel PJ, Shige H, Pomeroy S, Cehun M, Chin-Dusting J. Post-prandial remnant lipids impair arterial compliance. J Am Coll Cardiol 2001; 37: 1929-1935
26. Jagla A, Schrezenmeir J. Postprandial triglycerides and endothelial function. Exp Clin Endocrinol Diabetes 2001; 109: S533-S547
27. Kabagambe EK, Ordovas JM, Tsai MY, Borecki IB, Hopking PN, Blasser SP et al. Smoking, inflammatory patterns and postprandial hypertriglyceridemia. Atherosclerosis 2009; 203: 633-639
28. Leone A. Does smoking act as a friend or enemy of blood pressure? Let release Pandora's box. Cardiol Res Pract 2011; 2011: 264894
29. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN et al. Triglycerides and cardiovascular disease. A scientific statement from the American Heart Association. Circulation 2011; 123: 2292-2333
30. Mayer Jr O, Filipovsky J, Pesta M, Cifkova R, Dolejsova M, Simon J. The interaction of endothelial nitric oxide synthase polymorphism and current smoking in terms of increased arterial stiffness. Physiol Res 2010; 59: 529-536
31. Gustavsson J, Mehlig K, Leander K, Strandhagen E, Bjorck L, Thelle DS et al. Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women. Atherosclerosis 2012; 220: 486-492
32. Karvonen J, Kauma H, Kervinen K, Ukkola O, Rantala M, Paivansalo M et al. Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men. J Hypertens 2002; 20: 2372-2378
33. Bohnet K, Regis-Bailly A, Vincent-Viry M, Schlenck A, Gueguen R, Siest G et al. Apolipoprotein E genotype epsilon 4/epsilon 2 in the STANISLAS Cohort Study: Dominance of the epsilon 2 allele? Ann Hum Genet 1996; 60: 509-516
34. Woo D, Haverbusch M, Sekar P, Kissela B, Khoury J, Schneider A et al. Effect of untreated hypertension on hemorrhagic stroke. Stroke 2004; 35: 1703-1708
35. Kagan A, Yano K, Rhoads GG, McGee DL. Alcohol and cardiovascular disease: The Hawaiian experience. Circulation 1981; 64(Suppl III): 27-31
36. Chowdhury AH, Yokoyama T, Kokubo Y, Zaman MM, Haque A, Tanaka H. Apolipoprotein E genetic polymorphism and stroke subtypes in a Bangladeshi hospitalbased study. J Epidemiol 2001; 11: 131-138
37. Anuurad E, Rubin J, Lu G, Pearson TA, Holleran S, Ramakrishnan R et al. Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol. J Lipid Res 2006; 47: 2475-2481